Search
Powered By HealthLine
Special Offers
Health Tools
 Mammogram Guide
 Check A Breast Cancer Symptom
 Understanding Skin Cancer
 Skin Cancer Q&A
 Prostate Cancer Treatment
Featured Conditions
 Breast Cancer
 Skin Cancer
 Prostate
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Ovary Removal May Not Be Needed in Endometrial Cancer

In women 45 and younger, study finds no survival difference when ovaries left intact

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Optimistic Healing
Early Babies: How Soon is Too Soon?
Aqua Lipo
Cancer Treatment for Any Size
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
Focusing on School Could Prevent Teen Pregnancies
Low Vitamin D Tied to Estrogen Decline
Caring Through Sharing -- Life Changing Stories
Breast Cancer Pain Continues Years After Treatment
More...

MONDAY, Jan. 26 (HealthDay News) -- Younger women with early-stage endometrial cancer need not lose their ovaries when undergoing treatment for the cancer, a new study contends.

The largest study to date has found no difference in five-year survival rates among women who kept their ovaries and those who did not. Removal of the ovaries, called an oophorectomy, has long been a standard part of therapy for endometrial cancer.

Text Continues Below



However, "it appears that this is a safe thing if a woman wants to go ahead and keep her ovaries," said Dr. Jay Brooks, chairman of hematology/oncology at Ochsner Health System in Baton Rouge, La.

As always, though, no one decision is right for all women all the time.

"This is a retrospective study, so it's hard to say for sure that we should change practice based on this," said Dr. Jason D. Wright, assistant professor of obstetrics and gynecology at Columbia University College of Physicians & Surgeons in New York City and lead author of the study. "But it's definitely a provocative finding, and it does appear that ovarian preservation is safe."

"This is something that needs to be discussed with young women -- that this is available," he added. "Ideally, this would be tested in a prospective study."

The benefits of preserving the ovaries would be considerable. Young women would be spared the discomfort of hot flashes, vaginal dryness and other symptoms of induced menopause before their time. Also, avoiding the procedure would reduce the risk of cardiac disease and bone loss and would probably result in a longer life span.

The findings were published online Jan. 26 in the Journal of Clinical Oncology.

About 5 percent of endometrial cancer cases occur in women younger than 40. The average age is 60, and removing the ovaries is not really an issue for women after about age 50 because they have already undergone natural menopause, said Dr. Jeffrey Fowler, director of gynecologic oncology at the James Cancer Hospital and Solove Research Institute at Ohio State University in Columbus.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 1/27/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Jason D. Wright, M.D., assistant professor, obstetrics and gynecology, Columbia University College of Physicians and Surgeons, New York City; Jeffrey Fowler, M.D., director, gynecologic oncology, James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, Ohio; Jay Brooks, chairman, hematology/oncology, Ochsner Health System, Baton Rouge, La.; Jan. 26, 2009, Journal of Clinical Oncology


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy